Grants for Public housing authorities - Consumer Protection

This funding opportunity provides up to $1.5 million to organizations that can foster collaboration between the FDA and the generic drug industry, focusing on research and development of complex generics to improve access to safe and effective medications.

This funding opportunity supports innovative research and collaboration to develop therapies for ultra-rare cancers, targeting both pediatric and adult populations, and is open to a diverse range of applicants including nonprofits, educational institutions, and businesses.

This funding opportunity provides financial support to various organizations, including universities and non-profits, to improve veterinary diagnostic capabilities and address public health issues related to animal food safety and antimicrobial resistance.

This funding opportunity supports research aimed at developing innovative medical products for the prevention, diagnosis, and treatment of ALS and other rare neurodegenerative diseases, welcoming applications from a diverse range of organizations.

This funding opportunity provides $1 million to various organizations to develop innovative strategies that promote health equity and increase participation from underrepresented groups in clinical research.

This funding opportunity provides financial support for organizations to develop innovative educational programs that raise awareness about the risks associated with skin lightening products, particularly for minority communities.

This funding opportunity provides financial support for clinical trials aimed at developing new treatments for rare neurodegenerative diseases, benefiting a wide range of organizations including universities, nonprofits, and businesses across the country.

This funding opportunity provides $3 million to support research and outreach initiatives aimed at reducing health disparities among racial and ethnic minority populations, while also fostering training and mentorship for underrepresented students and early-career researchers.

This funding opportunity supports clinical research aimed at developing new treatments for rare diseases, targeting a wide range of eligible organizations, including universities, nonprofits, and small businesses.

This funding opportunity provides $2 million to a variety of organizations for research aimed at improving pain management, anesthesia safety, and addiction treatment through clinical trials and innovative methodologies.